Residual sympathetic tone is associated with reduced insulin sensitivity in patients with autonomic failure

Clinical Autonomic Research

Volumn 25, Issue 5, 2015, Pages 309-315

  Celedonio, Jorge E ^a   Arnold, Amy C ^a   Dupont, William D ^a   Ramirez, Claudia E ^a   Diedrich, André ^a   Okamoto, Luis E ^a   Raj, Satish R ^a   Robertson, David ^a   Peltier, Amanda C ^a   Biaggioni, Italo ^a   Shibao, Cyndya A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic failure; Hypertension; Insulin sensitivity; Sympathetic activity

Indexed keywords

CARBIDOPA PLUS LEVODOPA; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPH; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOLOGY ANALYZER; HUMAN; HYPERTENSION; INFORMATION PROCESSING; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NON INVASIVE BLOOD PRESSURE MONITOR; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PARKINSON DISEASE; RADIOIMMUNOASSAY; RADIOIMMUNOASSAY KIT; SHY DRAGER SYNDROME; SUPINE POSITION; SYMPATHETIC TONE; ADRENERGIC SYSTEM; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; HEART RATE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PHYSIOLOGY; PURE AUTONOMIC FAILURE;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PURE AUTONOMIC FAILURE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84944516831     PISSN: 09599851     EISSN: 16191560     Source Type: Journal    
DOI: 10.1007/s10286-015-0307-9     Document Type: Article

References (27)

1. Malik M (1996) The Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065
2. American Diabetes Association (2010) Standards of medical care in diabetes 2010. Diabetes Care 33(1):S11–S61
3. Arnold AC, Shibao C (2013) Current concepts in orthostatic hypotension management. Curr Hypertens Rep 15:304–312
4. Bergström B, Lilja B, Rosberg K, Sundkvist G (1986) Autonomic nerve function test. Reference values in healthy subjects. Clin Physiol 6:523–528
5. Broughton DL, Taylor R (1991) Review: deterioration of glucose tolerance with age: the role of insulin resistance. Age Ageing 20:221–225
6. Chalmanov V, Vurbanova M (1987) Diabetes mellitus in parkinsonism patients. Vutreshni bolesti 26:68–73
7. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72
8. Gamboa A, Okamoto LE, Arnold AC, Figueroa RA, Diedrich A, Raj SR, Paranjape SY, Farley G, Abumrad N, Biaggioni I (2014) Autonomic blockade improves insulin sensitivity in obese subjects. Hypertension 64:867–874
9. Gilman S, Low P, Quinn N, Albanese A, Ben Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology (Review) (26 refs). Clin Auton Res 8:359–362
10. Goldstein DS, Cannon RO, Quyyumi A, Chang P, Duncan M, Brush JE Jr., Eisenhofer G (1991) Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst 34:17–35
11. Henry S, Trueb L, Sartori C, Scherrer U, Jequier E, Tappy L (1998) Effects of a sympathetic activation by a lower body negative pressure on glucose and lipid metabolism. Clin Physiol 18:562–569
12. Jordan J, Biaggioni I (2002) Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension. J Clin Hypertens 4:139–145
13. Kaaja R, Kujala S, Manhem K, Katzman P, Kibarskis A, Antikainen R, Yliharsila H, Erkkola R, Tuomilehto J (2007) Effects of sympatholytic therapy on insulin sensitivity indices in hypertensive postmenopausal women. Int J Clin Pharmacol Ther 45:394–401
14. Karason K, Molgaard H, Wikstrand J, Sjostrom L (1999) Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 83:1242–1247
15. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191–2192
16. Marino JS, Xu Y, Hill JW (2011) Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol Metab 22:275–285
17. Maser RE, Lenhard MJ, Irgau I, Wynn GM (2007) Impact of surgically induced weight loss on cardiovascular autonomic function: one-year follow-up. Obesity (Silver Spring, Md.) 15:364–369
18. Mathias CJ, daCosta DF, Fosbraey P, Christensen NJ, Bannister R (1987) Hypotensive and sedative effects of insulin in autonomic failure. Br Med J 295:161–163
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
20. Okamoto LE, Gamboa A, Shibao C, Black BK, Diedrich A, Raj SR, Robertson D, Biaggioni I (2009) Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension 53:363–369
21. Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S, Mayeux R (2003) The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60:87–93
22. Schwab RS (1960) Progression and prognosis in Parkinson’s disease. J Nerv Ment Dis 130:556–566
23. Shannon JR, Jordan J, Diedrich A, Pohar B, Black BK, Robertson D, Biaggioni I (2000) Sympathetically mediated hypertension in autonomic failure. Circulation 101:2710–2715
24. Shibao C, Buchowski MS, Chen KY, Yu C, Biaggioni I (2012) Chronic sympathetic attenuation and energy metabolism in autonomic failure. Hypertension 59:985–990
25. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R (1991) Age as independent determinant of glucose tolerance. Diabetes 40:44–51
26. Smith GD, Alam M, Watson LP, Mathias CJ (1995) Effect of the somatostatin analogue, octreotide, on exercise-induced hypotension in human subjects with chronic sympathetic failure. Clin Sci 89:367–373
27. Spielman LJ, Little JP, Klegeris A (2014) Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration. J Neuroimmunol 273:8–21